Financials data is unavailable for this security.
View more
Year on year Manhattan Scientifics Inc had revenues fall -100.00% from 50.00k to 0.00, though the company grew net income from a loss of 2.73m to a smaller loss of 1.17m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -328.46% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Manhattan Scientifics Inc fell by 108.00k. However, Cash Flow from Investing totalled 102.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 190.00k for operations while cash used for financing totalled 20.00k.
| Cash flow per share | -0.0019 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.0042 |
|---|---|
| Tangible book value per share | -0.0042 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.0186 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
